Publications

Enders, F.B., Bader-Meunier, B., Baildam, E., Constantin, T., Dolezalova, P., Feldman, B.M., Lahdenne, P., Magnusson, B., Nistala, K., Pilkington, C.A., Ozen, S., Ravelli, A., Russo, R., Uziel, Y., van Brussel, M., van der Net, J., Vastert, S., Wedderburn L.R., Wulffraat, N., McCann, L.J., and van Royen-Kerkhof, A (2017).
Consensus - Based Recommendations for the Management of Juvenile Dermatomyositis.
Deakin, C.T., Yasin, S.A., Simou, S., Arnold, K., Tansley, S.L., Betteridge, Z.E, McHugh, N.J., Nistala, K., Varsani, H., Holton, J.L., Jacques, T.S., Pilkington, C.A., Wedderburn, L.R. (2016).
Muscle Biopsy in combination with myositis specific autoantibodies aids prediction of outcome in juvenile dermatomyositis (JDM).
Tansley S. L., Betteridge, Z.E., Simou, S., Jacques, T.S., Pilkington, C., Wood, M., Warrier, K., Wedderburn L.R., & J McHugh, N. J., on behalf of the JDRG. (2017).
Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients.
Rothwell, S., Cooper, R.G., Lundberg, I.E., Miller, F.W., Gregersen, P.K., Bowes, J., Vencovsky, J., Danko, K., Limaye, V., O’Callaghan, A.S., Hanna, M.G., Machado, P., Pachman, L.M., Reed, A.M., Rider, L.G., Cobb, J., Platt, H., Molberg, Ø., Benveniste, O., Mathiesen, P., Radstake, T., Doria, A., De Bleecker, J., De Paepe, B., Maurer, B., Ollier, W.E., Padyukov, L., O’Hanlon, T.P., Lee, A., Wedderburn, L.R., Chinoy, H., Lamb, J.A, and the Genetics Consortium (2015).
Dense genotyping of immune-related loci in the Idiopathic Inflammatory Myopathies Confirms HLA alleles as Strongest Genetic Risk Factor and Suggests Different Genetic Background for Major Clinical Subgroups.
Miller, F. W., Chen, W., O’Hanlon, T.P., Cooper, R.G., Vencovsky, J., Rider, L.G., Danko, K., Wedderburn, L.R., Lundberg, I.E., Pachman, L.M., Reed, A.M., Ytterberg, S.R., Padyukov, L., Selva-O’Callagham, A., Radstake, T., Isenberg, D.A., Chinoy, H., Ollier, W.E.R., Scheet, P., Peng, B., Lee, A., Lamb, A.J., Gregerson, P.K., Amos, C.I with the Myositis Genetics Consortium (2015).
Genome-wide Association Study Identifies HLA 8.1 Ancestral Haplotype alleles as the Major Genetic Risk Factors for Myositis Phenotypes.
McCann, L.J., Kirkham, J.J., Wedderburn, L.R., Pilkington, C.A., Huber, A.M., Ravelli, A., Appelbe, D., Williamson, P.R., Beresford, M.W. (2015).
Development of an internationally agreed minimal dataset for Juvenile Dermatomyositis (JDM) for clinical and research use.
Almeida, B., Campanilho-Marques, R., Arnold, K., Pilkington, C.A., Wedderburn, L.R., Nistala, K., behalf of the Juvenile Dermatomyositis Research Group (JDRG), (2015).
Analysis of published criteria for Clinically Inactive Disease in a large Juvenile Dermatomyositis cohort shows that skin disease is underestimated.
Vercoulen, V., Bellutti Enders, F., Meerding, J., Plantinga, M., Elst, E.F., Varsani, H., van Schieveen, C., Bakker, M.H., Klein, M., Scholman, R.C., Spliet, W., Ricotti, V., Koenen, H.J.P.M., de Weger, R.A., Wedderburn, L.R., Royen-Kerkhof, A., Prakken, B.J (2014)
Increased Presence of FOXP3+ Regulatory T Cells in Inflamed Muscle of Patients with Active Juvenile Dermatomyositis Compared to Peripheral Blood
}))